Skip to main content

Advertisement

Log in

Effects of short-term estrogen treatment on the progression of N-methyl-N-nitrosourea-induced premalignant mammary lesions in female Lewis rats

  • Published:
Medical Molecular Morphology Aims and scope Submit manuscript

Abstract

We studied the effects of short-term estrogen treatment (STET) on the progression of mammary lesions from ductal hyperplasia (DH) through ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) in the N-methyl-N-nitrosourea (MNU)-induced rat mammary carcinogenesis model. Three-week-old female Lewis rats (n = 40) received an intraperitoneal injection of MNU (50 mg/kg). Three weeks later, a 3-week-release, 0.25-mg, 17β-estradiol pellet was subcutaneously implanted for 2 weeks in 20 rats (STET); the remaining 20 rats did not receive the estradiol pellets (age-matched control). All rats were killed at 12 weeks of age, and their abdominal-inguinal mammary glands were histologically examined. The incidence and multiplicity of DHs were similar between groups (STET, 90% and 3.9 ± 0.6 vs. age-matched controls, 80% and 3.0 ± 0.5). However, DCIS and IDC did not develop in STET rats, whereas DCIS (25% and 1.4 ± 0.2) and IDC (35% and 1.4 ± 0.3) developed in the age-matched controls. Immunoscores of estrogen and progesterone receptors and positive rate of proliferative cell nuclear antigen (PCNA) in DH were similar in both groups, while the positive rate of cyclin D1 was significantly reduced in the STET group (P < 0.05). Thus, STET blocked the progression from DH to DCIS in MNU-induced mammary carcinogenesis, and decreased expression of cyclin D1 may play an important role in the blockade of cell transition from DH to DCIS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Coughlin SS, Ekwueme DU (2009) Breast cancer as a global health concern. Cancer Epidemiol 33:315–318

    Article  PubMed  Google Scholar 

  2. Platet N, Cathiard AM, Gleizes M, Garcia M (2004) Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 51:55–67

    Article  PubMed  Google Scholar 

  3. Nandi S, Guzman RC, Thordarson G, Rajkumar L (2005) Estrogen can prevent breast cancer by mimicking the protective effect of pregnancy. In: Li JJ, Li SA, Llombart-Bosch A (eds) Hormonal carcinogenesis, vol IV. Springer, New York, pp 165–179

    Google Scholar 

  4. Tsubura A, Uehara N, Matsuoka Y, Yoshizawa K, Yuri T (2008) Estrogen and progesterone treatment mimicking pregnancy for protection from breast cancer. In Vivo 22:191–202

    PubMed  CAS  Google Scholar 

  5. Santen RJ (2007) The oestrogen paradox: a hypothesis. Pol J Endocrinol 58:222–227

    Google Scholar 

  6. Thompson HJ, McGinley JN, Rothhammer K, Singh M (1995) Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis (Oxf) 16:2407–2411

    Article  CAS  Google Scholar 

  7. Thompson HJ, McGinley JN, Wolfe P, Singh M, Steele VE, Kelloff GJ (1998) Temporal sequence of mammary intraductal proliferations, ductal carcinomas in situ and adenocarcinomas induced by 1-methyl-1-nitrosourea in rats. Carcinogenesis (Oxf) 19:2181–2185

    Article  CAS  Google Scholar 

  8. Singh M, McGinley JN, Thompson HJ (2000) A comparison of the histopathology of premalignant and malignant mammary gland lesions induced in sexually immature rats with those occurring in the human. Lab Invest 80:221–231

    Article  PubMed  CAS  Google Scholar 

  9. Tsubura A, Yoshizawa K, Uehara N, Yuri T, Matsuoka Y (2007) Multistep mouse mammary tumorigenesis through pre-neoplasia to neoplasia and acquisition of metastatic potential. Med Mol Morphol 40:9–17

    Article  PubMed  Google Scholar 

  10. Isaacs JT (1986) Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. Cancer Res 46:3958–3963

    PubMed  CAS  Google Scholar 

  11. Yang J, Yoshizawa K, Nandi S, Tsubura A (1999) Protective effects of pregnancy and lactation against N-methyl-N-nitrosoureainduced mammary carcinomas in female Lewis rats. Carcinogenesis (Oxf) 20:623–628

    Article  Google Scholar 

  12. Silvera SAN, Rohan TE (2008) Benign proliferative epithelial disorders of the breast: a review of the epidemiologic evidence. Breast Cancer Res Treat 110:397–409

    Article  PubMed  Google Scholar 

  13. Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O’Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ (1999) Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:966–978

    Google Scholar 

  14. Moriya T, Kasajima A, Ishida K, Kariya Y, Akahira J, Endoh M, Watanabe M, Sasano H (2006) New trends of immunohistochemistry for making differential diagnosis of breast lesions. Med Mol Morphol 39:8–13

    Article  PubMed  CAS  Google Scholar 

  15. Thompson HJ, Singh M, McGinley J (2000) Classification of premalignant and malignant lesions developing in the rat mammary gland after injection of sexually immature rats with 1-methyl-1-nitrosourea. J Mammary Gland Biol Neoplasia 5:201–210

    Article  PubMed  CAS  Google Scholar 

  16. Tan PH, Aw MY, Yip G, Bay BH, Sii LH, Murugaya S, Tse GM (2005) Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ? Am J Surg Pathol 29:625–632

    Article  PubMed  Google Scholar 

  17. Huggins C, Moon RC, Morii S (1962) Extinction of experimental mammary cancer. I. Estradiol-17beta and progesterone. Proc Natl Acad Sci U S A 48:379–386

    Article  PubMed  CAS  Google Scholar 

  18. Rajkumar L, Guzman RC, Yang J, Thordarson G, Talamantes F, Nandi S (2001) Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc Natl Acad Sci U S A 98:11755–11759

    Article  PubMed  CAS  Google Scholar 

  19. Rajkumar L, Kittrell FS, Guzman RC, Brown PH, Nandi S, Medina D (2007) Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models. Breast Cancer Res 9:R12

    Article  PubMed  Google Scholar 

  20. MacMahon B, Cole P, Brown J (1973) Etiology of human breast cancer: a review. J Natl Cancer Inst 50:21–42

    PubMed  CAS  Google Scholar 

  21. Korkola JE, Wood GA, Archer MC (1999) Cyclin D1 expression during rat mammary tumor development and its potential role in the resistance of the Copenhagen rat. Breast Cancer Res 1:88–94

    Article  PubMed  CAS  Google Scholar 

  22. Thompson HJ, McGinley J, Rothhammer K, Singh M (1998) Ovarian hormone dependence of pre-malignant and malignant mammary gland lesions induced in pre-pubertal rats by 1-methyl-1-nitrosourea. Carcinogenesis (Oxf) 19:383–386

    Article  CAS  Google Scholar 

  23. Taylor D, Pearce CL, Hovanessian-Larsen L, Downey S, Spicer DV, Bartow S, Pike MC, Wu AH, Hawes D (2009) Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast. Breast Cancer Res Treat 118:161–168

    Article  PubMed  CAS  Google Scholar 

  24. Krishnamurthy S, Sneige N (2002) Molecular and biologic markers of premalignant lesions of human breast. Adv Anat Pathol 9: 185–197

    Article  PubMed  Google Scholar 

  25. Sivaraman L, Hilsenbeck SG, Zhong L, Gay J, Conneely OM, Medina D, O’Malley BW (2001) Early exposure of the rat mammary gland to estrogen and progesterone blocks co-localization of estrogen receptor expression and proliferation. J Endocrinol 171: 75–83

    Article  PubMed  CAS  Google Scholar 

  26. Hunter T, Pines J (1994) Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79:573–582

    Article  PubMed  CAS  Google Scholar 

  27. Zhu XL, Hartwick W, Rohan T, Kandel R (1998) Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma. Mod Pathol 11:1082–1088

    PubMed  CAS  Google Scholar 

  28. Dong Y, Asch HL, Medina D, Ip C, Ip M, Guzman R, Asch BB (1999) Concurrent deregulation of gelsolin and cyclin D1 in the majority of human and rodent breast cancers. Int J Cancer 81: 930–938

    Article  PubMed  CAS  Google Scholar 

  29. Alle KM, Henshall SM, Field AS, Sutherland RL (1998) Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. Clin Cancer Res 4:847–854

    PubMed  CAS  Google Scholar 

  30. Zhu Z, Jiang W, Thompson HJ (1999) Effect of energy restriction on the expression of cyclin D1 and p27 during premalignant and malignant stages of chemically induced mammary carcinogenesis. Mol Carcinog 24:241–245

    Article  PubMed  CAS  Google Scholar 

  31. Sgambato A, Han EK, Zhang YJ, Moon RC, Santella RM, Weinstein IB (1995) Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors. Carcinogenesis (Oxf) 16:2193–2198

    Article  CAS  Google Scholar 

  32. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV (1994) Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (Lond) 369:669–671

    Article  CAS  Google Scholar 

  33. Sutherland RL, Musgrove EA (2004) Cyclins and breast cancer. J Mammary Gland Biol Neoplasia 9:95–104

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takashi Yuri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yuri, T., Lai, YC., Kanematsu, S. et al. Effects of short-term estrogen treatment on the progression of N-methyl-N-nitrosourea-induced premalignant mammary lesions in female Lewis rats. Med Mol Morphol 44, 125–130 (2011). https://doi.org/10.1007/s00795-010-0515-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00795-010-0515-2

Key words

Navigation